8-K 1 f8k_031517.htm FORM 8-K

Washington, D.C. 20549

Form 8-K


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event Reported): March 15, 2017  

Rockwell Medical, Inc.
(Exact Name of Registrant as Specified in Charter)

MICHIGAN 000-2366138-3317208
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)


30142 Wixom Road, Wixom, Michigan 48393
(Address of Principal Executive Offices) (Zip Code)

(248) 960-9009
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 [ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 [ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 [ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 [ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02. Results of Operations and Financial Condition.

            On March 15, 2017, the Company issued the press release attached hereto as Exhibit 99.1, announcing its financial results for the quarter and year ended December 31, 2016.


Item 9.01. Financial Statements and Exhibits.

The following exhibit is furnished with this Form 8-K:

Exhibit Description
99.1 Press Release dated March 15, 2017.



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 Rockwell Medical, Inc.
Date: March 15, 2017By: /s/ Thomas E. Klema        
  Thomas E. Klema
  Its: Chief Financial Officer


Exhibit Description
99.1 Press Release dated March 15, 2017.